ENTITY
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

62
Analysis
Health CareChina
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
Refresh
bullishGiant Biogene
23 Oct 2022 22:12

Giant Biogene IPO: Valuation First Look

Giant Biogene will launch its US$500 million HKEx IPO this week. In this note, we present our forecasts and take the first look at its potential...

Logo
255 Views
Share
bullishGiant Biogene
19 Oct 2022 09:51

Giant Biogene Pre-IPO - Thoughts on Valuation

Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.

Logo
204 Views
Share
bullishGiant Biogene
18 Oct 2022 09:50

Giant Biogene Pre-IPO - Peer Comparison - Might Need to Spend a Lot More Online

Giant Biogene Holding  aims to raise around US$500m in its Hong Kong IPO. In this note, we will undertake a peer comparison.

Logo
273 Views
Share
17 Oct 2022 08:50

Bloomage Biotechnology (688363.CH) - Positioning and Strategic Layout Imply Strong Upside Potential

Synthetic biology/industrial chain integration help Bloomage build high moat.Synergy of multiple business improve the resilience to market...

Logo
176 Views
Share
bullishGiant Biogene
13 Oct 2022 08:46

Pre-IPO Giant Biogene - The Strength and the Concerns

Giant Biogene is in an industry that has big potential for growth in valuation. How to build long-term system advantage/core competitiveness is an...

Logo
218 Views
Share
x